FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Terry Bowlin

Research Profile

Living Beings

Chemicals & Drugs

Physiology

Lymphocyte Activation

Anatomy

Co-author Network

Publications

TOP 3
Karen Meerovitch; Frédéric Bergeron; Lorraine Leblond; Brigitte Grouix; Cathy Poirier; Monica Bubenik; Laval Chan; Henriette Gourdeau; Terry Bowlin; Giorgio Attardo
A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagen.
Henriette Gourdeau; Lucie Bibeau; France Ouellet; Dominique Custeau; L Bernier; Terry Bowlin
Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity.
DL Taylor; Parvin Ahmed; AS Tyms; L J Wood; L A Kelly; P Chambers; J Clarke; J Bedard; Terry Bowlin; RF Rando
Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Terry Bowlin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Karen Meerovitch; Frédéric Bergeron; Lorraine Leblond; Brigitte Grouix; Cathy Poirier; Monica Bubenik; Laval Chan; Henriette Gourdeau; Terry Bowlin; Giorgio Attardo
A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagen.
Vascular pharmacology 2003;40(2):77-89.
2001: Henriette Gourdeau; Lucie Bibeau; France Ouellet; Dominique Custeau; L Bernier; Terry Bowlin
Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity.
Cancer chemotherapy and pharmacology 2001;47(3):236-40.
2000: DL Taylor; Parvin Ahmed; AS Tyms; L J Wood; L A Kelly; P Chambers; J Clarke; J Bedard; Terry Bowlin; RF Rando
Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
Antiviral chemistry & chemotherapy 2000;11(4):291-301.
2000: N Richard; Horacio Salomon; RF Rando; TS Mansour; Terry Bowlin; Mark A Wainberg
Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine.
Antimicrobial agents and chemotherapy 2000;44(5):1127-31.
1999: Z Gu; Mark A Wainberg; Nghe Nguyen-Ba; Lucille L'Heureux; JM de Muys; Terry Bowlin; RF Rando
Mechanism of action and in vitro activity of 1',3'-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants.
Antimicrobial agents and chemotherapy 1999;43(10):2376-82.
1999: DL Taylor; Parvin Ahmed; P Chambers; AS Tyms; J Bedard; J Duchaine; Guy Falardeau; JF Lavallée; W Brown; RF Rando; Terry Bowlin
Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
Antiviral chemistry & chemotherapy 1999;10(2):79-86.
1999: J Bedard; S May; M Lis; L Tryphonas; J Drach; J Huffman; R Sidwell; Laval Chan; Terry Bowlin; RF Rando
Comparative study of the anti-human cytomegalovirus activities and toxicities of a tetrahydrofuran phosphonate analogue of guanosine and cidofovir.
Antimicrobial agents and chemotherapy 1999;43(3):557-67.
1999: J Bedard; S May; D Barbeau; L Yuen; RF Rando; Terry Bowlin
A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors.
Antiviral research 1999;41(1):35-43.
1999: N Richar; Yudong Quan; Horacio Salomon; M Hsu; J Bedard; P Richard Harrigan; RF Rando; TS Mansour; Terry Bowlin; Mark A Wainberg
Selection and characterization of HIV-1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine (dOTC).
Antiviral therapy 1999;4(3):171-7.
1998: Shafaat A Rabbani; P Harakidas; Terry Bowlin; Giorgio Attardo
Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.
Cancer research 1998;58(15):3461-5.
1997: Salam Kadhim; Terry Bowlin; W R Waud; E G Angers; Lucie Bibeau; J M DeMuys; K Bednarski; A Cimpoia; Giorgio Attardo
Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.
Cancer research 1997;57(21):4803-10.
1996: A L Akeson; C W Woods; L C Hsieh; R A Bohnke; B L Ackermann; K Y Chan; J L Robinson; S D Yanofsky; J W Jacobs; Ronald W Barrett; Terry Bowlin
AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1.
The Journal of biological chemistry 1996;271(48):30517-23.
1996: S D Yanofsky; D N Baldwin; J H Butler; F R Holden; J W Jacobs; P Balasubramanian; J P Chinn; Steven E Cwirla; E Peters-Bhatt; E A Whitehorn; E H Tate; A Akeson; Terry Bowlin; William J Dower; Ronald W Barrett
High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(14):7381-6.
1995: H Schreuder; C Tardif; Adolfo Soffientini; Edoardo Sarubbi; A Akeson; Terry Bowlin; S Yanofsky; Ronald W Barrett
Crystals of soluble interleukin-1 receptor complexed with its natural antagonist reveal a 1:1 receptor-ligand complex.
FEBS letters 1995;373(1):39-40.
1995: H A Schreuder; J M Rondeau; C Tardif; Adolfo Soffientini; Edoardo Sarubbi; A Akeson; Terry Bowlin; S Yanofsky; Ronald W Barrett
Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline.
European journal of biochemistry / FEBS 1995;227(3):838-47.
1994: K Schroeder; Terry Bowlin; G Bridges; D Taylor; A S Tyms; A D Cardin
Specific interaction of 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid with human cellular CD4.
Cellular immunology 1994;159(1):103-10.
1993: M S Kang; Terry Bowlin; I K Vijay; S P Sunkara
Accumulation of pentamannose oligosaccharides in human mononuclear leukocytes by action of swainsonine, an inhibitor of glycoprotein processing.
Carbohydrate research 1993;248():327-37.
1993: J A Wolos; K A Frondorf; George Babcock; S A Stripp; Terry Bowlin
Immunomodulation by an inhibitor of S-adenosyl-L-homocysteine hydrolase: inhibition of in vitro and in vivo allogeneic responses.
Cellular immunology 1993;149(2):402-8.
1993: J A Wolos; K A Frondorf; G F Davis; E T Jarvi; J R McCarthy; Terry Bowlin
Selective inhibition of T cell activation by an inhibitor of S-adenosyl-L-homocysteine hydrolase.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(8 Pt 1):3264-73.
1993: J F French; K K Schroeder; A L Akeson; R C Dage; Terry Bowlin
Identification of a specific receptor for interleukin-1 in vascular smooth muscle cells: regulation by interleukin-1 and interleukin-6.
European journal of pharmacology 1993;233(1):109-12.
1992: A L Akeson; L B Mosher; C W Woods; K K Schroeder; Terry Bowlin
Human aortic endothelial cells express the type I but not the type II receptor for interleukin-1 (IL-1).
Journal of cellular physiology 1992;153(3):583-8.
1992: N J Prakash; G F Davis; E T Jarvi; M L Edwards; J R McCarthy; Terry Bowlin
Antiretroviral activity of mechanism-based irreversible inhibitors of S-adenosylhomocysteine hydrolase.
Life sciences 1992;50(19):1425-35.
1991: Terry Bowlin; K K Schroeder; B O Fanger
Swainsonine, an inhibitor of mannosidase II during glycoprotein processing, enhances concanavalin A-induced T cell proliferation and interleukin 2 receptor expression exclusively via the T cell receptor complex.
Cellular immunology 1991;137(1):111-7.
1991: A D Cardin; P L Smith; L Hyde; D T Blankenship; Terry Bowlin; K Schroeder; K A Stauderman; D L Taylor; A S Tyms
Stilbene disulfonic acids. CD4 antagonists that block human immunodeficiency virus type-1 growth at multiple stages of the virus life cycle.
The Journal of biological chemistry 1991;266(20):13355-63.
1991: PS Wright; D E Cross-Doersen; K K Schroeder; Terry Bowlin; P P McCann; Alan J Bitonti
Disruption of Plasmodium falciparum-infected erythrocyte cytoadherence to human melanoma cells with inhibitors of glycoprotein processing.
Biochemical pharmacology 1991;41(12):1855-61.
1991: DL Taylor; P S Sunkara; P S Liu; M S Kang; Terry Bowlin; A S Tyms
6-0-butanoylcastanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIVs.
AIDS (London, England) 1991;5(6):693-8.
1991: E T Jarvi; J R McCarthy; S Mehdi; D P Matthews; M L Edwards; N J Prakash; Terry Bowlin; P S Sunkara; Philippe Bey
4',5'-unsaturated 5'-halogenated nucleosides. Mechanism-based and competitive inhibitors of S-adenosyl-L-homocysteine hydrolase.
Journal of medicinal chemistry 1991;34(2):647-56.
1991: R G Brankamp; G G Manley; D T Blankenship; Terry Bowlin; A D Cardin
Studies on the anticoagulant, antimetastatic and heparin-binding properties of ghilanten-related inhibitors.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1991;2(1):161-6.
1991: Terry Bowlin; N J Prakash; M L Edwards; A Sjoerdsma
Participation of T-lymphocytes in the curative effect of a novel synthetic polyamine analogue, N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine, against L1210 leukemia in vivo.
Cancer research 1991;51(1):62-6.
1990: Terry Bowlin; A Rosenberger; D Stemerick; M L Edwards
Potentiation of natural killer cell activity and tumor immunity by diacetylputrescine.
Cancer research 1990;50(17):5460-3.
1990: N J Prakash; Terry Bowlin; M L Edwards; P S Sunkara; A Sjoerdsma
Antitumor activity of a novel synthetic polyamine analogue, N,N'-bis-[3-(ethylamino)-propyl]-1-7-heptane diamine: potentiation by polyamine oxidase inhibitors.
Anticancer research 1990;10(5A):1281-7.
1990: Terry Bowlin; B J Hoeper; A L Rosenberger; G F Davis; P S Sunkara
Effects of three irreversible inhibitors of ornithine decarboxylase on macrophage-mediated tumoricidal activity and antitumor activity in B16F1 tumor-bearing mice.
Cancer research 1990;50(15):4510-4.
1990: J A Wolos; D E Logan; Terry Bowlin
Methylacetylenic putrescine (MAP), an inhibitor of polyamine biosynthesis, prevents the development of collagen-induced arthritis.
Cellular immunology 1990;125(2):498-507.
1990: P S Sunkara; M S Kang; Terry Bowlin; P S Liu; A S Tyms; A Sjoerdsma
Inhibition of glycoprotein processing and HIV replication by castanospermine analogues.
Annals of the New York Academy of Sciences 1990;616():90-6.
1989: Terry Bowlin; B J McKown; M S Kang; P S Sunkara
Potentiation of human lymphokine-activated killer cell activity by swainsonine, an inhibitor of glycoprotein processing.
Cancer research 1989;49(15):4109-13.
1989: Terry Bowlin; A L Rosenberger; B J McKown
Alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, augments cyclosporin A inhibition of cytolytic T lymphocyte induction.
Clinical and experimental immunology 1989;77(1):151-6.
1989: P S Sunkara; DL Taylor; M S Kang; Terry Bowlin; P S Liu; A S Tyms; A Sjoerdsma
Anti-HIV activity of castanospermine analogues.
Lancet 1989;1(8648):1206.
1989: P S Sunkara; Terry Bowlin; A L Rosenberger; W R Fleischmann
Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice.
Journal of biological response modifiers 1989;8(2):170-9.
1989: Terry Bowlin; B J McKown; K K Schroeder
Methyl-acetylenicputrescine (MAP), an inhibitor of polyamine biosynthesis, reduces the frequency and cytolytic activity of alloantigen-induced LyT 2.2 positive lymphocytes in vivo.
International journal of immunopharmacology 1989;11(3):259-65.
1988: A D Cardin; Terry Bowlin; John Leonard Krstenansky
Inhibition of lymphocyte proliferation by synthetic peptides homologous to human plasma apolipoproteins B and E.
Biochemical and biophysical research communications 1988;154(2):741-5.
1988: N J Prakash; Terry Bowlin; G F Davis; P S Sunkara; A Sjoerdsma
Antitumor activity of norspermidine, a structural homologue of the natural polyamine spermidine.
Anticancer research 1988;8(4):563-8.
1988: Terry Bowlin; Alan J Bitonti; B J McKown
Decreased interleukin-2 responsiveness in leukocytes from Trypanosoma brucei-infected mice.
Cellular immunology 1988;112(2):437-41.
1988: Terry Bowlin; P S Sunkara
Swainsonine, an inhibitor of glycoprotein processing, enhances mitogen induced interleukin 2 production and receptor expression in human lymphocytes.
Biochemical and biophysical research communications 1988;151(2):859-64.
1988: Terry Bowlin; G F Davis; B J McKown
Inhibition of alloantigen-induced cytolytic T lymphocytes in vitro with (2R,5R)-6-heptyne-2,5-diamine, an irreversible inhibitor of ornithine decarboxylase.
Cellular immunology 1988;111(2):443-50.
1988: P S Sunkara; J H Zwolshen; N J Prakash; Terry Bowlin
Mechanism of antitumor activity of norspermidine, a structural homologue of spermidine.
Advances in experimental medicine and biology 1988;250():707-16.
1987: P S Sunkara; Terry Bowlin; P S Liu; A Sjoerdsma
Antiretroviral activity of castanospermine and deoxynojirimycin, specific inhibitors of glycoprotein processing.
Biochemical and biophysical research communications 1987;148(1):206-10.
1987: Terry Bowlin; B J McKown; George Babcock; P S Sunkara
Intracellular polyamine biosynthesis is required for interleukin 2 responsiveness during lymphocyte mitogenesis.
Cellular immunology 1987;106(2):420-7.
1987: Terry Bowlin; B J McKown; P S Sunkara
The effect of alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on mitogen-induced interleukin 2 production.
Immunopharmacology 1987;13(2):143-7.
1987: Terry Bowlin; B J McKown; P S Sunkara
Increased ornithine decarboxylase activity and polyamine biosynthesis are required for optimal cytolytic T lymphocyte induction.
Cellular immunology 1987;105(1):110-7.
1986: Terry Bowlin; B J McKown; G F Davis; P S Sunkara
Effect of polyamine depletion in vivo by DL-alpha-difluoromethylornithine on functionally distinct populations of tumoricidal effector cells in normal and tumor-bearing mice.
Cancer research 1986;46(11):5494-8.
1986: Terry Bowlin; B J McKown; P S Sunkara
Ornithine decarboxylase induction and polyamine biosynthesis are required for the growth of interleukin-2- and interleukin-3-dependent cell lines.
Cellular immunology 1986;98(2):341-50.
1986: Terry Bowlin; A L Rosenberger; B J McKown; G F Davis; P S Sunkara
The effect of alpha-difluoromethylornithine on natural killer cell and tumoricidal macrophage induction by interferon in vivo.
International journal of immunopharmacology 1986;8(2):131-6.
1985: Terry Bowlin; A L Rosenberger; P S Sunkara
The effect of combination treatment with alpha-difluoromethylornithine and Corynebacterium parvum on B16 melanoma growth and tumoricidal effector cell generation in vivo.
Cancer immunology, immunotherapy : CII 1985;20(3):214-8.